Health knowledge and news provided by doctors.

Poniard To Presents Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial

Armen Hareyan's picture

Small Cell Lung Cancer Trial

Poniard Pharmaceuticals announced that data from a Phase 2 trial of picoplatin in patients with small cell lung cancer will be presented in a poster session at the 43rd Annual Meeting of the American Society of Clinical Oncology.

Follow eMaxHealth on YouTube, Twitter and Facebook.
Please, click to subscribe to our Youtube Channel to be notified about upcoming health and food tips.

Details are as follows:

-- Abstract #7722, Poster #EE3